NEWS

  • All
  • Corporate News
  • Media
All
  • All
  • Corporate News
  • Media
Corporate News

Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update

Read More
Corporate News

Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom

Read More
Corporate News

Mainz Biomed Announces Collaboration with Fugene Genetics in Israel

Read More
Corporate News

Mainz Biomed Secures up to $50M in New Funding

Read More
Corporate News

Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain

Read More
Corporate News

Mainz Biomed Expands into Romania Through Partnership with Bioclinica

Read More